Details of the Drug

General Information of Drug (ID: DMA14FD)

Drug Name
TU-2100
Indication
Disease Entry ICD 11 Status REF
Psoriasis vulgaris EA90 Discontinued in Phase 2 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C27H32O8
Canonical SMILES
CCOC(=O)C1=CC=CC=C1OC(=O)CCCCCCCC(=O)OC2=CC=CC=C2C(=O)OCC
InChI
InChI=1S/C27H32O8/c1-3-32-26(30)20-14-10-12-16-22(20)34-24(28)18-8-6-5-7-9-19-25(29)35-23-17-13-11-15-21(23)27(31)33-4-2/h10-17H,3-9,18-19H2,1-2H3
InChIKey
LIBAUACOIKWWKP-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
4342838
CAS Number
207972-39-2
TTD ID
D0P3TF

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013307)